290 related articles for article (PubMed ID: 33861527)
1. Recent progress of nanotechnology-based theranostic systems in cancer treatments.
Xue Y; Gao Y; Meng F; Luo L
Cancer Biol Med; 2021 Apr; 18(2):336-51. PubMed ID: 33861527
[TBL] [Abstract][Full Text] [Related]
2. Nanotheranostics: The Fabrication of Theranostics with Nanoparticles and their Application to Treat the Neurological Disorders.
Singh A; Patel A; Chaudhary H; Yadav K; Minocha N
Recent Pat Nanotechnol; 2023 Jul; ():. PubMed ID: 37464820
[TBL] [Abstract][Full Text] [Related]
3. Surface Engineering of Nanoparticles toward Cancer Theranostics.
Huang P; Wang C; Deng H; Zhou Y; Chen X
Acc Chem Res; 2023 Jul; 56(13):1766-1779. PubMed ID: 37314368
[TBL] [Abstract][Full Text] [Related]
4. Nanotheranostics - application and further development of nanomedicine strategies for advanced theranostics.
Muthu MS; Leong DT; Mei L; Feng SS
Theranostics; 2014; 4(6):660-77. PubMed ID: 24723986
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography and nanotechnology: A dynamic duo for cancer theranostics.
Goel S; England CG; Chen F; Cai W
Adv Drug Deliv Rev; 2017 Apr; 113():157-176. PubMed ID: 27521055
[TBL] [Abstract][Full Text] [Related]
6. 2D Nanomaterials for Cancer Theranostic Applications.
Cheng L; Wang X; Gong F; Liu T; Liu Z
Adv Mater; 2020 Apr; 32(13):e1902333. PubMed ID: 31353752
[TBL] [Abstract][Full Text] [Related]
7. Responsive theranostic systems: integration of diagnostic imaging agents and responsive controlled release drug delivery carriers.
Caldorera-Moore ME; Liechty WB; Peppas NA
Acc Chem Res; 2011 Oct; 44(10):1061-70. PubMed ID: 21932809
[TBL] [Abstract][Full Text] [Related]
8. Albumin Carriers for Cancer Theranostics: A Conventional Platform with New Promise.
Chen Q; Liu Z
Adv Mater; 2016 Dec; 28(47):10557-10566. PubMed ID: 27111654
[TBL] [Abstract][Full Text] [Related]
9. One stone, many birds: Recent advances in functional nanogels for cancer nanotheranostics.
Wang H; Picchio ML; Calderón M
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jul; 14(4):e1791. PubMed ID: 35338603
[TBL] [Abstract][Full Text] [Related]
10. Nanotechnological selection.
Demming A
Nanotechnology; 2013 Jan; 24(2):020201. PubMed ID: 23242125
[TBL] [Abstract][Full Text] [Related]
11. Two-dimensional cancer theranostic nanomaterials: Synthesis, surface functionalization and applications in photothermal therapy.
Murugan C; Sharma V; Murugan RK; Malaimegu G; Sundaramurthy A
J Control Release; 2019 Apr; 299():1-20. PubMed ID: 30771414
[TBL] [Abstract][Full Text] [Related]
12. Challenges to effective cancer nanotheranostics.
Melancon MP; Stafford RJ; Li C
J Control Release; 2012 Dec; 164(2):177-82. PubMed ID: 22906841
[TBL] [Abstract][Full Text] [Related]
13. Recent Progress in the Theranostics Application of Nanomedicine in Lung Cancer.
Mukherjee A; Paul M; Mukherjee S
Cancers (Basel); 2019 Apr; 11(5):. PubMed ID: 31035440
[TBL] [Abstract][Full Text] [Related]
14. Advancing cancer theranostics through biomimetics: A comprehensive review.
Anitha K; Chenchula S; Surendran V; Shvetank B; Ravula P; Milan R; Chikatipalli R; R P
Heliyon; 2024 Mar; 10(6):e27692. PubMed ID: 38496894
[TBL] [Abstract][Full Text] [Related]
15. Graphene as cancer theranostic tool: progress and future challenges.
Orecchioni M; Cabizza R; Bianco A; Delogu LG
Theranostics; 2015; 5(7):710-23. PubMed ID: 25897336
[TBL] [Abstract][Full Text] [Related]
16. NIR-II Organic Nanotheranostics for Precision Oncotherapy.
Dai H; Wang X; Shao J; Wang W; Mou X; Dong X
Small; 2021 Nov; 17(44):e2102646. PubMed ID: 34382346
[TBL] [Abstract][Full Text] [Related]
17. Smart Multifunctional Nanoparticles in Cancer Theranostics: Progress and Prospect.
Karati D; Mukherjee S; Dutta A; Ash D; Ganguly SC; Acharya A; Basu B
Pharm Nanotechnol; 2024 May; ():. PubMed ID: 38756071
[TBL] [Abstract][Full Text] [Related]
18. Nanomaterials incorporated ultrasound contrast agents for cancer theranostics.
Fu L; Ke HT
Cancer Biol Med; 2016 Sep; 13(3):313-324. PubMed ID: 27807499
[TBL] [Abstract][Full Text] [Related]
19. Advances in nanobased platforms for cardiovascular diseases: Early diagnosis, imaging, treatment, and tissue engineering.
Shariati L; Esmaeili Y; Rahimmanesh I; Babolmorad S; Ziaei G; Hasan A; Boshtam M; Makvandi P
Environ Res; 2023 Dec; 238(Pt 1):116933. PubMed ID: 37652218
[TBL] [Abstract][Full Text] [Related]
20. Current trends in theranostics for rheumatoid arthritis.
Madav Y; Barve K; Prabhakar B
Eur J Pharm Sci; 2020 Mar; 145():105240. PubMed ID: 31987984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
